JP2547371B2 - Feeding method for crustacean, fish feed, and fish feed - Google Patents

Feeding method for crustacean, fish feed, and fish feed

Info

Publication number
JP2547371B2
JP2547371B2 JP5063361A JP6336193A JP2547371B2 JP 2547371 B2 JP2547371 B2 JP 2547371B2 JP 5063361 A JP5063361 A JP 5063361A JP 6336193 A JP6336193 A JP 6336193A JP 2547371 B2 JP2547371 B2 JP 2547371B2
Authority
JP
Japan
Prior art keywords
fish
test
feed
group
survival rate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP5063361A
Other languages
Japanese (ja)
Other versions
JPH0622705A (en
Inventor
橋 幸 則 高
丹 利 明 伊
園 勲 宮
尾 健 松
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZENKOKU NOGYO KYODOKUMIAI RENGOKAI
Original Assignee
ZENKOKU NOGYO KYODOKUMIAI RENGOKAI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZENKOKU NOGYO KYODOKUMIAI RENGOKAI filed Critical ZENKOKU NOGYO KYODOKUMIAI RENGOKAI
Priority to JP5063361A priority Critical patent/JP2547371B2/en
Publication of JPH0622705A publication Critical patent/JPH0622705A/en
Application granted granted Critical
Publication of JP2547371B2 publication Critical patent/JP2547371B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明はエビ類,カニ類,及び魚
類に投与する甲殻類及び魚類用飼料に関する。ここでエ
ビ類とはクルマエビ(Penaeus japonicus) ,ウシエビ(P
enaeus monodon) ,コウライエビ(Penaeus chinensis)
,及びバナナエビ(Penaeus morguiensis) 等のクルマ
エビ属やその他の海水性,淡水性エビ類を含み、カニ類
とは海水性,淡水性のすべてのカニ類を包含し、かつ魚
類とは海水性,淡水性魚類を包含する。
TECHNICAL FIELD The present invention relates to a crustacean and fish feed for administration to shrimps, crabs, and fish. Here, prawns are prawns (Penaeus japonicus) and bull shrimp (P
enaeus monodon), Black shrimp (Penaeus chinensis)
, And Kuruma prawns such as banana shrimp (Penaeus morguiensis) and other seawater and freshwater shrimp. Crabs include all seawater and freshwater crabs, and fish are seawater and freshwater. Includes sex fish.

【0002】[0002]

【従来の技術及び発明が解決しようとする課題】近年、
甲殻類及び魚類の養殖が盛んに行われているが、感染症
の発生が多いために、死亡または発育遅延等による経済
的損失が極めて大きく、養殖産業上問題となっている。
前記感染症にはビブリオ属やその他の細菌による感染
症,及びバキュロウイルスやその他のウイルスによる感
染症がある。
2. Description of the Related Art In recent years,
Cultivation of crustaceans and fish is actively carried out, but due to the frequent occurrence of infectious diseases, economic loss due to death or growth delay is extremely large, which is a problem in the aquaculture industry.
The infectious diseases include infectious diseases caused by Vibrio spp. And other bacteria, and infectious diseases caused by baculovirus and other viruses.

【0003】現在、これらの疾病の予防,治療に種々の
抗生物質,サルファ剤等の抗菌剤が使用されているが、
その効果は必ずしも十分とは云えず、しかも近年抗生物
質等の抗菌剤は生体内への残留や薬剤耐性菌の出現など
により人体への影響が問題視され極力制限される方向に
ある。
At present, various antibacterial agents such as antibiotics and sulfa drugs are used for the prevention and treatment of these diseases.
The effect is not always sufficient, and in recent years, antibacterial agents such as antibiotics have a tendency to be restricted as much as possible due to their residual effects in the living body and the appearance of drug-resistant bacteria, which have an adverse effect on the human body.

【0004】本発明は前記した事情に鑑みてなされたも
のであり、その目的は給餌によって甲殻類及び魚類の生
体防御機能を賦活し、生体機能並びに免疫機能を増強す
ると共に増体効果を奏する甲殻類,魚類用飼料,及び魚
類用飼料の給餌方法を提供するにある。
The present invention has been made in view of the above-mentioned circumstances, and the purpose thereof is to activate the biological defense function of crustaceans and fish by feeding, enhance the biological function and the immune function, and exert a weight gain effect. The present invention provides a feed for fish, fish feed, and fish feed.

【0005】[0005]

【課題を解決するための手段】本発明の甲殻類,魚類用
飼料は前記した目的を達成するため、飼料中にグラム陽
性菌,酵母類,真菌類由来のペプチドグリカンを添加し
たことを特徴としている。また、本発明の魚類用飼料の
給餌方法は、魚類に対するペプチドグリカンの一日当り
の投与量とその適正投与期間の関係を予備試験により設
定し、ペプチドグリカン含有飼料を前記投与量に相当す
る割合で前記適正投与期間連日投与することを特徴とし
ている。
Means for Solving the Problems In order to achieve the above-mentioned object, the crustacean and fish feed of the present invention is characterized by adding peptidoglycan derived from Gram-positive bacteria, yeasts and fungi to the feed. . Further, the feeding method of the fish feed of the present invention, the relationship between the daily dose of peptidoglycan to fish and its proper administration period is set by a preliminary test, and the peptidoglycan-containing feed is appropriately fed at a ratio corresponding to the above dose. Administration period It is characterized by daily administration.

【0006】[0006]

【作用】ペプチドグリカン(以下、PGと略称する)は
生体内に採り込まれて、血球の貪食活性を高めるなど、
生体防御機能を増強させ、これによって免疫増強及び体
重増加をもたらす。また、PGは魚類に対する投与量と
その適正投与期間の関係を有しており、過剰に投与し続
けても効果が軽減する。
[Function] Peptidoglycan (hereinafter, abbreviated as PG) is taken up in the body to enhance phagocytic activity of blood cells.
It enhances the defense function of the body, thereby enhancing immunity and weight gain. Further, PG has a relationship between the dose for fish and its proper administration period, and the effect is diminished even if it is continuously administered in excess.

【0007】[0007]

【実施例】以下、本発明を具体的な試験例によって詳細
に説明する。試験例 1 試験方法: 平均体重25gのクルマエビを30尾ずつ
の4群に分け、本発明区1,2,3区には飼料中にPG
をエビの体重1Kgあたり1日量として、それぞれ0.
05,0.2,1.0mgとなるように添加して1日お
きに与えた。本発明区のPG無投与の日と対照区にはP
G無添加の同一飼料を与えた。このような方法で7日間
飼育したのち、8日後にエビの心臓から採血して、ME
M培地中で血液1mlあたり107 個のラテックスビー
ズ(直径0.81ミクロン)を混合し、45分後に血球
100細胞中のビーズ取込み細胞数および血球100細
胞中に取込まれたビーズ総数を調べた。
EXAMPLES The present invention will be described in detail below with reference to specific test examples. Test Example 1 Test method: Kuruma prawns having an average body weight of 25 g were divided into 4 groups of 30 fish each, and PG was added to the feed in the present groups 1, 2 and 3
Is a daily dose per 1 kg of body weight of shrimp.
It was added so as to be 05, 0.2 and 1.0 mg and given every other day. On the day without PG administration of the present invention group and P on the control group
The same feed without G was fed. After breeding for 7 days in this way, 8 days later, blood was collected from the shrimp heart and
10 7 latex beads (0.81 micron diameter) were mixed per 1 ml of blood in M medium, and after 45 minutes, the number of beads taken up in 100 cells of blood cells and the total number of beads taken up in 100 cells of blood cells were examined. It was

【0008】結果: 本発明区および対照区のクルマエ
ビにおける血球100細胞あたりのラテックスビーズを
取込んだ血球細胞数を図1に示した。対照区では平均3
8.2個の血球がラテックスビーズを取込んでいたのに
対し、0.05mg区は平均59.0細胞,0.2mg
区は平均62.5細胞,1.0mg区は平均53.0細
胞であり、いずれのPG投与区においても対照区にくら
べてより多くの血球細胞がラテックスビーズを貪食して
いた。
Results: The number of blood cells incorporating latex beads per 100 blood cells in the prawns of the present invention and the control was shown in FIG. Average of 3 in the control area
8.2 blood cells had incorporated latex beads, while 0.05 mg group had an average of 59.0 cells, 0.2 mg.
The group had an average of 62.5 cells and the 1.0 mg group had an average of 53.0 cells, and in any PG-administered group, more blood cells were phagocytosed with the latex beads than in the control group.

【0009】また、血球100細胞当たりの取込まれた
ラテックスビーズの総数を図2に示した。対照区では平
均134個のビーズが取込まれていたのに対し、0.0
5mg区では平均372個,0.2mg区が平均450
個,1.0mg区が313個であり、いずれの本発明区
においても対照区にくらべてより多くのビーズが血球内
に取込まれていた。以上のことからクルマエビにPGを
投与することにより血球の貪食活性が高まることが明ら
かになった。また、図1,図2からPGを投与する際に
最適投与量が存在することが示唆された。
The total number of incorporated latex beads per 100 blood cells is shown in FIG. Compared to the average of 134 beads taken up in the control, 0.0
Average of 372 in 5 mg group, 450 in 0.2 mg group
The number of beads was 1.03 mg, and the number of 1.0 mg groups was 313, and more beads were taken up in blood cells in each of the present invention groups than in the control group. From the above, it became clear that the phagocytic activity of blood cells was enhanced by administering PG to the prawns. Moreover, it was suggested from FIGS. 1 and 2 that there is an optimum dose when PG is administered.

【0010】試験例 2 試験方法: クルマエビの稚エビ(PL30,平均体重
0.01g)を流水式の500リットル水槽2槽に20
0尾ずつ収容し、試験開始後60日に各々を5トン水槽
に移し、計95日間飼育した。本発明区にはPGをエビ
の体重1Kgあたり1日量として0.2mgとなるよう
に添加した飼料を1週間与え、次の1週間はPG無添加
飼料を与える方法を試験終了時まで反復した。対照区に
は常時PG無添加飼料を与えた。そして、PGの効果を
確認するために、以下の項目について調べた。 (1) 試験開始後60日,75日,95日目のエビの生残
率 (2) 試験開始後60日,75日,95日目のエビの体重 (3) 試験開始後60日,75日,95日目のエビにおけ
る実験感染に対する防御効果 尚、試験項目(3) の実験感染については、クルマエビの
ビブリオ病原因菌Vibrio sp.を1.7〜2.
7×107 細胞/ml,懸濁した海水中にPG投与開始
後67日目および95日目のエビを30尾ずつ1時間浸
漬し、その後10日間の生残率を調べた。
Test Example 2 Test Method: Juvenile prawns (PL30, average weight 0.01 g) were put in two 500-liter water tanks of running water type 20.
Each of them was housed 0, and 60 days after the start of the test, each was transferred to a 5-ton aquarium and bred for a total of 95 days. The present invention group was fed with a feed supplemented with PG in an amount of 0.2 mg per 1 kg of body weight of shrimp for 1 week, and for the next 1 week, a method of feeding a PG-free feed was repeated until the end of the test. . The control group was always fed with PG-free feed. Then, in order to confirm the effect of PG, the following items were examined. (1) Shrimp survival rate 60, 75, 95 days after the start of the test (2) Shrimp weight 60, 75, 95 days after the start of the test (3) 60 days, 75 after the start of the test Protective effect against experimental infection in shrimp on day 95, the experimental infection of the test item (3), Vibrio sp. 1.7-2.
30 shrimp on the 67th day and the 95th day after the start of PG administration were immersed in 7 × 10 7 cells / ml of suspended seawater for 1 hour each, and then the survival rate for 10 days was examined.

【0011】結果: (1) 試験期間中の本発明区および
対照区のクルマエビの生残率を表1に示した。
Results: (1) Table 1 shows the survival rate of the prawns of the present invention group and the control group during the test period.

【表1】 注)( )内の数字は生残尾数/供試尾数を示す。[Table 1] Note) The numbers in parentheses indicate the number of surviving fish / the number of test fish.

【0012】このように、試験終了時の生残率は、本発
明区が58.5%であったのに対し、対照区が30.5
%であり、前者の生残率がすぐれていた。また、斃死し
たエビについて細菌検査を行ったところ、本発明区の一
部と対照区のほとんどのエビからビブリオ属細菌が分離
された。したがって、本発明区の生残率が対照区のそれ
より高かった原因についてはPGによって生体防御機能
が促進され、ビブリオなどによる細菌感染を防御したも
のと考えられる。
As described above, the survival rate at the end of the test was 58.5% in the present invention group, whereas it was 30.5% in the control group.
%, And the survival rate of the former was excellent. In addition, when a bacterium was tested for dead shrimp, a bacterium of the genus Vibrio was isolated from a part of the present invention and most of the control. Therefore, it is considered that the reason why the survival rate of the present invention group was higher than that of the control group was that PG promoted the biological defense function and protected the bacterial infection due to Vibrio etc.

【0013】(2) 試験期間中の本発明区および対照区の
クルマエビの平均体重を表2に示した。
(2) Table 2 shows the average body weight of the prawns of the present invention group and the control group during the test period.

【表2】 注)数字は平均値±標準偏差を示す。 このように、試験終了時の平均体重は、本発明区が2.
58gであったのに対し、対照区が2.00gであり、
前者の成長がすぐれていた。
[Table 2] Note) Numbers are mean ± standard deviation. Thus, the average weight at the end of the test was 2.
While it was 58 g, the control group was 2.00 g,
The former was growing well.

【0014】(3) 本発明区および対照区のクルマエビに
おける実験感染後の生残率の推移を図3及び図4に示し
た。すなわち、試験開始後67日目のクルマエビをVi
brio sp.の菌液に1時間浸漬後の生残率は本発
明区が1日後に86.7%,2日後に76.7%とな
り、それ以後の斃死はみられなかった。対照区は感染1
日後に56.7%,2日後に30%,3日後に26.7
%となり、最終生残率は26.7%であった(図3参
照)。
(3) Changes in the survival rate after experimental infection in the prawns of the present invention group and the control group are shown in FIGS. 3 and 4. That is, the prawns on the 67th day after the start of the test
brio sp. The survival rate after 1 hour of immersion in the bacterial solution was 86.7% after 1 day and 76.7% after 2 days, and no mortality was observed thereafter. Control area is infected 1
56.7% after day, 30% after 2 days, 26.7 after 3 days
%, And the final survival rate was 26.7% (see FIG. 3).

【0015】試験開始後95日目のクルマエビをVib
rio sp.の菌液に1時間浸漬後の生残率は、本発
明区が3日後に86.7%,4日後に80%となり、最
終生残率は80%であった。対照区は感染1日後に7
3.3%,2日後に56.7%,3日後に33.3%と
なり、最終生残率は33.3%であった。(図4参
照)。このように、本発明区はいずれも実験感染後の生
残率が有意(p<0.01)に高かった。この原因につ
いては、PGによってクルマエビの血球の貪食活性を中
心とする生体防御機能が高まったことが考えられる。
95 days after the start of the test
rio sp. The survival rate after immersion in the bacterial solution for 1 hour was 86.7% after 3 days in the present invention group and 80% after 4 days, and the final survival rate was 80%. 7 days after infection in the control area
The rate was 3.3%, 56.7% after 2 days, 33.3% after 3 days, and the final survival rate was 33.3%. (See Figure 4). As described above, the survival rate after experimental infection was significantly high (p <0.01) in all of the present invention plots. Regarding this cause, it is considered that PG enhanced the biological defense function centered on the phagocytic activity of the blood cells of Shrimp prawn.

【0016】試験例 3 試験方法: PGを含む微細飼料(PG5mg/Kg飼
料)をウシエビのゾエア期,ミシス期およびポストラー
バ(PL15)期の幼生に毎日投与して、生残率を調べ
ると共にゾエア期からミシス期への変態率を調べた。
尚、微細飼料の投与量は幼生1尾あたり、ゾエア期で
0.16mg/日,ミシス期では0.2mg/日,ポス
トラーバ期では0.24mg/日とした。飼料の投与量
から換算したPGの幼生1尾あたり1日の投与量は、ゾ
エア期で5×10-7mg,ミシス期で6.25×10-7
mg,ポストラーバ期で7.5×10-7mgであった。
この投与量は幼生の体重1KgあたりのPG1日量とし
て、およそ0.1〜0.2mgとなる。
Test Example 3 Test method: A fine feed containing PG (PG 5 mg / Kg feed) was daily administered to larvae of the zoea, mysis and post-lava (PL15) stages of the shrimp to examine the survival rate and zoea stage. The rate of transformation from to the Mitsis stage was investigated.
The dose of the fine feed was 0.16 mg / day in the zoea stage, 0.2 mg / day in the mesis stage, and 0.24 mg / day in the post-rava stage per larva. The daily dose per larva of PG calculated from the dose of feed was 5 × 10 -7 mg in the Zoea period and 6.25 × 10 -7 in the Mesis period.
mg, 7.5 × 10 −7 mg in the post-lava period.
This dose is about 0.1 to 0.2 mg as the daily dose of PG per 1 kg of body weight of the larva.

【0017】結果: 本発明区および対照区のウシエビ
のゾエア期からミシス期への変態率とゾエア期からポス
トラーバ期(PL15)までの生残率を表3に示した。
Results: Table 3 shows the rate of transformation of the shrimp of the present invention group and the control group from the zoea stage to the mesis stage and the survival rate from the zoea stage to the post-lava stage (PL15).

【表3】 [Table 3]

【0018】ウシエビはクルマエビなどにくらべると、
幼生期の生残率が著しく低く、通常20%前後であると
いわれている。しかし、表3に示すように、PGを投与
することによって生残率が高まるとともに、変態率が向
上することが明らかになった。
Compared to car shrimp and the like, bull shrimp
The survival rate in the larval period is extremely low, and is said to be usually around 20%. However, as shown in Table 3, it was revealed that administration of PG increases the survival rate and the transformation rate.

【0019】試験例 4 試験方法: 平均体重約58gのアユを表4に示す試験
区分に従い、各区400尾ずつを2つの池に分けて試験
に供試した。供試魚は2×1×1mのコンクリート池で
1カ月間飼育した。飼育期間中の水温は約20〜23℃
であった。本発明区には基礎飼料にPGを外割りで添加
し、ペレットクランブルに成型したのち、PGの投与量
が1日に魚体重1Kg当たり0.01〜1.0mgにな
るように試験飼料を給与した。尚、対照区にはPG無添
加の飼料を給与した。
Test Example 4 Test Method: Ayu having an average body weight of about 58 g were divided into two ponds according to the test section shown in Table 4 and subjected to the test. The test fish were bred for 1 month in a 2 × 1 × 1 m concrete pond. The water temperature during the breeding period is about 20-23 ° C.
Met. In the present invention group, PG was added to the basic feed in an external proportion and molded into pellet crumble, and then the test feed was fed so that the dose of PG was 0.01 to 1.0 mg per 1 kg of fish body weight per day. did. The control group was fed with PG-free feed.

【0020】結果: PG添加飼料を1カ月間給与した
後、各区10尾ずつのアユの尾部血管より採血し、分雛
して得た血漿が2×10cells/mlのウサギ赤
血球を20℃で90分間に溶血する割合を求めたのち、
その半量を溶血させる血漿量の逆数をACH50値とし
て求めた。その結果を表4及び図5に示した。尚、AC
50値は平均値±標準誤差で示した。
Results: After feeding the PG-added feed for 1 month, blood was collected from the tail blood vessels of 10 ayu from each group, and the blood plasma obtained by the chick feeding was 2 × 10 7 cells / ml of rabbit red blood cells at 20 ° C. After obtaining the ratio of hemolysis in 90 minutes,
The reciprocal of the plasma volume for hemolyzing half the amount was determined as the ACH 50 value. The results are shown in Table 4 and FIG. In addition, AC
H 50 values were expressed as mean ± standard error.

【0021】[0021]

【表4】 注)異符号間にDANCANの検定による5%水準の有
意差あり。
[Table 4] Note) There is a significant 5% level difference between different signs by DANCAN test.

【0022】表4及び図5に示すとおり、すべての本発
明区のACH50値は対照区に比べ高い傾向がみられ、
PG添加飼料の投与によりアユの血漿のACH50値が
上昇することを確認した。ただし、PGを0.1mg投
与したときの値が最も高く、1.0mg投与した区では
0.1mg投与した区よりむしろ低い傾向がみられたこ
とから、PGを投与する際には最適投与量が存在するこ
とが示唆された。尚、ACH50値は補体代替経路によ
る抗原への攻撃能力を表すが、近年貧食細胞や末梢血リ
ンパ球に補体のひとつであるC3のレセプターが存在す
る可能性が報告(松山等、平成3年度日本魚病学会春季
大会講演要旨集、西村等、日水誌、57(12)、22
19(1991))されていることから、補体は貧食細
胞や末梢血リンパ球を活性化させる能力をも有し、魚類
の生体防御機能として重要な役割を果たしていると思わ
れる。また、魚類のACH50値は哺乳類に比べ著しく
高いことから、魚類の場合、古典経路よりも系統発生学
的に古いと言われている代替経路に依存する率が高いと
も考えられている(矢野等、日水誌、54(6)、10
49(1988))。本試験において、PGの投与によ
り魚類の生体防御能力が向上することを確認した。
As shown in Table 4 and FIG. 5, the ACH 50 values of all the present invention plots tended to be higher than those of the control plots,
It was confirmed that the ACH 50 value of the plasma of ayu increases by the administration of the PG-added feed. However, the value was highest when 0.1 mg of PG was administered and tended to be lower in the 1.0 mg group than in the 0.1 mg group. Have been suggested to exist. The ACH 50 value represents the ability to attack antigens by the complement alternative pathway, but in recent years it has been reported that the receptor for C3, which is one of the complements, may be present in phagocytes and peripheral blood lymphocytes (Matsuyama et al. 1991 Spring Meeting of the Japanese Society of Fish Diseases, Nishimura et al., Nisui, 57 (12), 22
19 (1991)), it is considered that complement also has the ability to activate phagocytic cells and peripheral blood lymphocytes, and plays an important role as a biological defense function of fish. In addition, since the ACH 50 value of fish is significantly higher than that of mammals, it is considered that fish have a higher rate of dependence on alternative pathways which are said to be phylogenetically older than the classical pathway (Yano). Etc., Nisshi, 54 (6), 10
49 (1988)). In this test, it was confirmed that the administration of PG improves the biological defense ability of fish.

【0023】試験例 5 試験方法: 平均体重約0.1gの浮上直後のニジマス
稚魚を表5に示す試験区分に従い、各区800尾ずつを
4つの水槽に分けて試験に供試した。供試魚は60リッ
トル容のガラス水槽にて4週間飼育した。飼育期間中の
水温は15〜16℃であった。本発明区には基礎飼料に
PGを外割で添加したものを、0.3〜0.5mm径に
成型したのち、PGの投与量が1日に魚体重1kg当た
り0.01〜0.1mgになるように給与した。尚、対
照区にはPG無添加飼科を給与した。
Test Example 5 Test Method: Frying rainbow trout juveniles having an average body weight of about 0.1 g immediately after ascending were subjected to the test according to the test classification shown in Table 5 by dividing 800 fish in each section into four aquariums. The test fish were bred for 4 weeks in a 60-liter glass water tank. The water temperature during the breeding period was 15 to 16 ° C. In the present invention group, after adding PG to the basic feed in an outer percentage, it was molded into a diameter of 0.3 to 0.5 mm, and the dose of PG was 0.01 to 0.1 mg per 1 kg of fish body weight per day. I was paid to become. The control group was fed a PG-free diet.

【0024】結果: PG添加飼料を4週間給与した
後、各区40尾ずつのニジマスを取り上げ、2.5×1
〜2.5×10CFU/mlのVibrio a
nguillaremを懸濁させた生理食塩水に30分
間浸漬して、21日間の生残率を測定した。尚、非感染
区は細菌フリーの生理食塩水に30分間浸漬した。その
結果を表5,図6(2.5×10CFU/mlの結
果)、及び図7(2.5×10CFU/mlの結果)
に示した。
Results: After feeding PG-added feed for 4 weeks, 40 rainbow trouts in each ward were picked up and 2.5 × 1
Vibrio a of 0 5 to 2.5 × 10 6 CFU / ml
It was dipped in a physiological saline solution in which nguillarem was suspended for 30 minutes, and the survival rate for 21 days was measured. The non-infected area was immersed in physiological saline free of bacteria for 30 minutes. The results are shown in Table 5 and FIG. 6 (results of 2.5 × 10 5 CFU / ml), and FIG. 7 (results of 2.5 × 10 6 CFU / ml).
It was shown to.

【0025】[0025]

【表5】 [Table 5]

【0026】表5及び図6,図7に示すとおり、2.5
×10GFU/ml攻撃及び2.5×10CFU/
ml攻撃の場合ともに、対照区の生残率に比べて、すべ
ての本発明区の生残率が有意に優れていた。PGの投与
により、ニジマス稚魚の免疫機能が活性化された結果、
Vibrio anguillarumに対する抗病性
を獲得したものと思われる。本試験において、PGの投
与により魚類の生体防御能力が向上することを確認し
た。尚、非感染区の生残率が100%であったことか
ら、感染試験中における魚の斃死原因は攻撃に用いたV
ibrio anguillarumによる感染症であ
ると考えられる。
As shown in Table 5 and FIGS. 6 and 7, 2.5
× 10 5 GFU / ml attack and 2.5 × 10 6 CFU / ml
In both cases of ml attack, the survival rates of all the inventive plots were significantly superior to those of the control plots. As a result of the activation of the immune function of juvenile rainbow trout by the administration of PG,
It is considered that it has acquired the disease resistance against Vibrio anguillarum. In this test, it was confirmed that the administration of PG improves the biological defense ability of fish. Since the survival rate in the non-infected area was 100%, the cause of death of the fish during the infection test was the V used for the attack.
It is considered to be an infection caused by ibrio anguillarum.

【0027】試験例 6 試験方法: 平均体重200gのウナギを表6に示す試
験区分に従い、各区30尾ずつを試験に供試した。供試
魚は2×1×1mのコンクリート池で1カ月間飼育し
た。本発明区には基礎飼料にPGを外割で添加し、2日
に1回、PGの投与量が1日に魚体重1kg当たり0.
2〜1.0mgになるように試験飼料を給与した。尚、
対照区にはPG無添加飼料を給与した。
Test Example 6 Test method: Eels having an average body weight of 200 g were subjected to the test according to the test categories shown in Table 6 with 30 fish in each group. The test fish were bred for 1 month in a 2 × 1 × 1 m concrete pond. In the present invention group, PG was added to the basic feed in an external proportion, and once every two days, the dose of PG was 0.1% per 1 kg of fish body weight per day.
The test feed was fed so as to be 2 to 1.0 mg. still,
The control group was fed with PG-free feed.

【0028】結果: PG添加飼料を1カ月給与した
後、ウナギ1尾当たり1×105 CFU のEdwardsiella t
ardaを腹腔内に接種し、20日間の生残率を調べた。そ
の結果を表6及び図8に示した。
Results: Edwardsiella t of 1 × 10 5 CFU per eel after feeding PG-added feed for 1 month
Arda was inoculated intraperitoneally and the survival rate for 20 days was examined. The results are shown in Table 6 and FIG.

【0029】[0029]

【表6】 注)表中、( )内の数字は対照区との間の有意差を示
す。
[Table 6] Note) In the table, the number in parentheses indicates a significant difference from the control.

【0030】表6及び図8に示すとおり、対照区の生残
率が53.3%であったのに対し、本発明区のPGを
0.2mg投与した区は90.0%と有意に高かった。
PGの投与により、ウナギの免疫機能が活性化された結
果、Edwardsilella tardaに対する
抗病性を獲得したものと思われる。しかし、PGを1.
0mg投与した区の生残率は73.3%であり、対照区
との間に有意な差がなかったことから、PGを投与する
際には最適投与量が存在することが示唆された。本試験
において、PGの投与により魚類の生体防御能力が向上
することを確認した。尚、細菌検査ならびに病理組織学
的検査の結果からウナギが斃死した原因はすべてEdw
ardsilella tardaの感染によるもので
あると判断された。
As shown in Table 6 and FIG. 8, the survival rate of the control group was 53.3%, whereas that of the group of the present invention to which 0.2 mg of PG was administered was 90.0%. it was high.
It is considered that the administration of PG resulted in the activation of the immune function of the eel, resulting in the acquisition of anti-pathogenicity against Edwardsilella tarda. However, PG is 1.
The survival rate of the 0 mg-administered group was 73.3%, and there was no significant difference from the control group, suggesting that there is an optimum dose when PG is administered. In this test, it was confirmed that the administration of PG improves the biological defense ability of fish. In addition, the cause of the death of the eel was all Edw based on the results of the bacterial and histopathological examinations.
It was determined to be due to infection with Ardsilella tarda.

【0031】試験例 7(PGの長期連続投与試験) 試験方法: 平均体重約20gのニジマスを表7に示す
試験区分に従い、各区160尾ずつを2つの池に分けて
試験に供試した。供試魚は紫外線殺菌装置のある循環式
の1.5tのFRP水槽にて24週間飼育した。飼育期
間中水温は17℃に調節した。本発明区は、基礎飼料に
PGを外割りで添加し、3.2mm径のペレットに成型
したのち、PGの投与量が1日に魚体重1kg当り0.
004mg〜4mgになるように試験飼料を給与した。
なお、対照区には、PG無添加の飼料を給与した。
Test Example 7 (Long-term continuous administration test of PG) Test method: According to the test classification shown in Table 7, rainbow trout having an average body weight of about 20 g was divided into two ponds, each of which had 160 fish, and used for the test. The test fish were bred for 24 weeks in a circulation type 1.5t FRP water tank equipped with an ultraviolet sterilizer. The water temperature was adjusted to 17 ° C during the breeding period. In the present invention group, PG was externally added to the basic feed and molded into pellets having a diameter of 3.2 mm, and then the dose of PG was adjusted to 0.
The test feed was fed so as to be 004 mg to 4 mg.
The control group was fed with PG-free feed.

【0032】結果: PG添加飼料を給与後、4週間毎
に各区10尾ずつのニジマスの尾部血管より採血し、分
離して得た血漿が、2×107 cells/mlのウサギ赤血球
を20℃で90分間に溶血する割合を求め、その半量を
溶血させる血漿量の逆数をACH50値として求めた。そ
の結果を表7に示す。
Results: After feeding the PG-added feed, blood was collected from the tail blood vessels of 10 rainbow trouts in each group every 4 weeks, and the separated plasma was 2 × 10 7 cells / ml of rabbit red blood cells at 20 ° C. The proportion of hemolysis in 90 minutes was determined, and the reciprocal of the plasma volume for hemolyzing half the amount was determined as the ACH 50 value. The results are shown in Table 7.

【0033】[0033]

【表7】 注)表中の数字はACH50値(units/ml)(平均±標準誤
差)である。 注)縦のラインにおける異符号間にDANCANの検定
による5%水準の有意差あり。
[Table 7] Note) The numbers in the table are ACH 50 values (units / ml) (mean ± standard error). Note) There is a significant difference of 5% level between different signs in the vertical line by DANCAN test.

【0034】表7に示すとおり、4週目においては0.
4mg投与区が、また、8週目においては0.004m
g、0.04mg、及び4mg投与区が対照区のACH
50値より高い値を示した。しかしながら、0.4mgと
4mg投与区は12週目において、また、0.004m
gは16週目、0.04mg投与区は20週目におい
て、それぞれ対照区よりむしろ活性が低くなった。この
ことは、PGには適正な投与量もしくは投与期間があ
り、過剰に投与し続けても効果が軽減することを示して
いる。以上の試験結果から、PGの投与によりニジマス
血漿のACH50値が上昇すること、およびPGには適正
な投与量と投与期間があり、1日に0.4mg投与する
場合は4週間、また、0.004mg〜0.04mg投
与する場合には8週間あるいは12週間が適当であるこ
とが判明した。この傾向は同じような生体防御機構をも
つ養殖対象魚種(マダイ,ブリ,ウナギ,アユ,コイ
等)においても同様に現れると考えられる。
As shown in Table 7, in the 4th week, 0.
The 4 mg dose was 0.004 m in the 8th week.
g, 0.04mg, and 4mg administration group is the control group ACH
The value was higher than 50 . However, the 0.4 mg and 4 mg dose groups were 0.004 m
The activity was lower than that in the control group at 16th week and 0.04mg administration group at 20th week, respectively. This indicates that PG has an appropriate dose or administration period, and the effect is diminished even if excessive administration is continued. From the above test results, the ACH 50 value of rainbow trout plasma is increased by administration of PG, and PG has an appropriate dose and administration period. When 0.4 mg is administered daily, it is 4 weeks, and It was found that 8 weeks or 12 weeks is appropriate when 0.004 mg to 0.04 mg is administered. It is considered that this tendency also appears in the fish species to be cultivated having the same biological defense mechanism (red sea bream, yellowtail, eel, sweetfish, carp, etc.).

【0035】試験例 8(PGに再えるエクストルージ
ョン加工の影響) 試験方法: 平均体重約20gのニジマスを表8に示す
試験区分に従い、各区160尾ずつを2つの水槽に分け
て試験に供試した。供試魚は紫外線殺菌装置のある循環
式の1.5tのFRP水槽にて4週間飼育した。飼育期
間中の水温は17℃に調節した。本発明区には基礎飼料
にPGを外割りで添加し、3.2mm径のペレットおよ
び約4mm径のエクスパンジョンペレットにそれぞれ成
型したのち、PGの投写量が1日に魚体重1kg当たり
0.04mgになるように試験飼料を給与した。なお、
対照区には、PG無添加飼料を給与した。
Test Example 8 (Effect of Extrusion Processing Reappearing on PG) Test Method: According to the test classification shown in Table 8, rainbow trout having an average body weight of about 20 g are divided into two aquariums, and 160 fish in each section are subjected to the test. did. The test fish were bred for 4 weeks in a circulation type 1.5 t FRP water tank equipped with an ultraviolet sterilizer. The water temperature during the breeding period was adjusted to 17 ° C. In the present invention group, PG was externally added to the basic feed and molded into 3.2 mm diameter pellets and about 4 mm diameter expansion pellets, respectively, and then the projected amount of PG was 0 per 1 kg of fish weight per day. The test feed was fed so that the amount would be 0.04 mg. In addition,
A PG-free feed was fed to the control plot.

【0036】結果: PG添加飼料を給与後、4週後に
各区10尾ずつのニジマス尾部血管より採血し、分離し
て得た血漿が、2×107 cells/mlのウサギ赤
血球を20℃で90分間に溶血する割合を求め、その半
量を溶血させる血漿量の逆数をACH50値として求め
た。その結果を表8に示す。
Results: Four weeks after feeding the PG-added feed, blood was collected from 10 rainbow trout tail blood vessels in each section, and the blood plasma obtained after separation was 2 × 10 7 cells / ml of rabbit red blood cells at 20 ° C. The rate of hemolysis per minute was determined, and the reciprocal of the plasma volume at which half the amount was hemolyzed was determined as the ACH 50 value. Table 8 shows the results.

【0037】[0037]

【表8】 注)表中数字は平均±標準誤差である。[Table 8] Note) Numbers in the table are mean ± standard error.

【0038】表8に示すとおり、エクスパンジョンペレ
ットにおいても、通常のペレットと遜色ないPG添加に
よるACH50値の上昇が確認された。エクスパンジョ
ンペレットは、飼料原料中のでんぷん質をα化させるこ
とにより、通常のペレットよりエネルギーの利用性が高
められることから、発育が優れることが知られている。
また、飼料の粉化が少なく、飼料が水に溶けにくいこと
から、養殖用水の汚染が著しく低減される。また、従
来、ペレットを食さないとされていた、ブリ等の海水魚
やウナギなどに給与することも可能である。以上の理由
から、近年普及しつつある新しい形態の飼料と言われて
いる。しかしながら、一般に、飼料をエクストルージョ
ン加工する際、10気圧程度の高い圧力と100℃以上
の高い温度等の過酷な物理的条件が加わるため、原料の
変成が問題となる。本試験により、PGがこのようなエ
クストルージョン加工の過酷な物理的条件の影響を受け
ず、魚類の生体防御機能を向上させ得ることを明らかに
した。このことは、PGが通常のペレットやマッシュ飼
料のみでなく、エクスパンジョンペレットにも使用が可
能であり、したがって、対象生物により様々な飼料形態
が要求される甲殻類および魚類用料科において、PGが
より幅広く利用可能であることを示している。
As shown in Table 8, also in the expansion pellets, it was confirmed that the ACH 50 value was increased by the addition of PG, which was comparable to the usual pellets. It is known that expansion pellets have higher energy utilization than normal pellets by converting the starch quality in the feed raw material into α, and thus are superior in growth.
Further, since the feed is less pulverized and the feed is less soluble in water, the contamination of aquaculture water is significantly reduced. It is also possible to feed saltwater fish such as yellowtail, eels, etc., which have not been eaten pellets in the past. For the above reasons, it is said to be a new form of feed that is becoming popular in recent years. However, generally, when the feed is subjected to the extrusion process, severe physical conditions such as a high pressure of about 10 atm and a high temperature of 100 ° C. or higher are added, so that the transformation of the raw material becomes a problem. This test revealed that PG can improve the biological defense function of fish without being affected by the severe physical conditions of such extrusion processing. This means that PG can be used not only for normal pellets and mash feeds, but also for expansion pellets, and thus in the shellfish and fish diets where various feed forms are required depending on the target organism, It shows that PG is more widely available.

【0039】以上述べたように本発明はエビ類,カニ類
の甲殻類及び魚類に給餌して甲殻類及び魚類の生体機能
並びに免疫機能を増強すると共に、増体効果を奏する。
As described above, the present invention feeds shrimp, crab crustaceans and fish to enhance the biological functions and immune functions of crustaceans and fish, and exerts a weight gain effect.

【0040】また、本発明の給餌方法によれば魚類の生
体機能並びに免疫機能を適確な目安によって達成するこ
とができると共に、その経済的効果も高いとする実操業
上のメリットをも奏する。
Further, according to the feeding method of the present invention, the biological function and the immune function of fish can be achieved by an appropriate standard, and at the same time, there is an advantage in actual operation that the economical effect thereof is high.

【図面の簡単な説明】[Brief description of drawings]

【図1】クルマエビの血球細胞の貪食活性を示すグラフ
である。
FIG. 1 is a graph showing the phagocytic activity of blood cells of prawns.

【図2】クルマエビの血球細胞の貪食活性を示すグラフ
である。
FIG. 2 is a graph showing the phagocytic activity of blood cells of prawns.

【図3】クルマエビのビブリオ実験感染後の生残率を示
すグラフである。
FIG. 3 is a graph showing the survival rate of Shrimp after infection with Vibrio esculenta.

【図4】クルマエビのビブリオ実験感染後の生残率を示
すグラフである。
FIG. 4 is a graph showing the survival rate of Shrimp after infection with the Vibrio test.

【図5】PG添加飼料を1カ月間投与したアユの血漿の
ACH50値を示すグラフである。
FIG. 5 is a graph showing the ACH 50 value of the plasma of sweetfish which was administered with PG-added feed for 1 month.

【図6】Vibrio anguillarum(2.5×105 CFU/
ml)で攻撃した後のPG投与ニジマスの生残率を示す
グラフである。
FIG. 6: Vibrio anguillarum (2.5 × 10 5 CFU /
(ml) is a graph showing the survival rate of PG-administered rainbow trout after challenge.

【図7】Vibrio anguillarum(2.5×106 CFU/
ml)で攻撃した後のPG投与ニジマスの生残率を示す
グラフである。
FIG. 7: Vibrio anguillarum (2.5 × 10 6 CFU /
(ml) is a graph showing the survival rate of PG-administered rainbow trout after challenge.

【図8】Edwardsiella tarda(1×105 CFU/m
l)で攻撃した後のPG投与ウナギの生残率を示すグラ
フである。
[Figure 8] Edwardsiella tarda (1 x 10 5 CFU / m
It is a graph which shows the survival rate of the PG administration eel after attacking by 1).

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 35/74 A61K 35/74 B 38/00 37/02 ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Office reference number FI technical display location A61K 35/74 A61K 35/74 B 38/00 37/02

Claims (2)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 グラム陽性菌,酵母類,真菌類由来のペ
プチドグリカンを添加したことを特徴とする甲殻類,魚
類用飼料。
1. A feed for crustaceans and fish, comprising peptidoglycan derived from Gram-positive bacteria, yeasts and fungi.
【請求項2】 魚類に対するペプチドグリカンの一日当
りの投与量とその適正投与期間の関係を予備試験により
設定し、ペプチドグリカン含有飼料を前記投与量に相当
する割合で前記適正投与期間連日投与することを特徴と
する魚類用飼料の給飼方法。
2. A relationship between the daily dose of peptidoglycan to fish and its appropriate administration period is set by a preliminary test, and peptidoglycan-containing feed is administered daily at the appropriate administration period at a rate corresponding to the above dose. Feeding method for fish feed.
JP5063361A 1992-03-03 1993-02-26 Feeding method for crustacean, fish feed, and fish feed Expired - Lifetime JP2547371B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5063361A JP2547371B2 (en) 1992-03-03 1993-02-26 Feeding method for crustacean, fish feed, and fish feed

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP4-82625 1992-03-03
JP8262592 1992-03-03
JP5063361A JP2547371B2 (en) 1992-03-03 1993-02-26 Feeding method for crustacean, fish feed, and fish feed

Publications (2)

Publication Number Publication Date
JPH0622705A JPH0622705A (en) 1994-02-01
JP2547371B2 true JP2547371B2 (en) 1996-10-23

Family

ID=26404471

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5063361A Expired - Lifetime JP2547371B2 (en) 1992-03-03 1993-02-26 Feeding method for crustacean, fish feed, and fish feed

Country Status (1)

Country Link
JP (1) JP2547371B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2989557B2 (en) * 1996-12-06 1999-12-13 株式会社椿本チエイン Article gripping device
NO339169B1 (en) * 2008-04-24 2016-11-14 Chemoforma Ltd Functional fish feed comprising peptidoglycan and nucleotides

Also Published As

Publication number Publication date
JPH0622705A (en) 1994-02-01

Similar Documents

Publication Publication Date Title
Chang et al. Immunomodulation by dietary β-1, 3-glucan in the brooders of the black tiger shrimpPenaeus monodon
JP2828799B2 (en) Method for producing yeast glucan
Novriadi Vibriosis in aquaculture
Cheng et al. Effects of intrinsic and extrinsic factors on the haemocyte profile of the prawn, Macrobrachium rosenbergii
Cheng et al. Effect of hypoxia on the immune response of giant freshwater prawn Macrobrachium rosenbergii and its susceptibility to pathogen Enterococcus
Mohan et al. Chitin, chitosan and chitooligosaccharides as potential growth promoters and immunostimulants in aquaculture: A comprehensive review
Keith et al. Defence mechanisms of the American lobster,(Homarus americanus): vaccination provided protection against gaffkemia infections in laboratory and field trials
JP2547371B2 (en) Feeding method for crustacean, fish feed, and fish feed
JP2002012552A (en) Immune activation-adjusting agent for human and animal, and method for preventing and treating infectious disease, skin disease and cancer of human and animal
JP2000103740A (en) Drug and feed for fishes and shellfishes
JPH0665649B2 (en) Crustacean biological defense enhancer, infectious disease preventive vaccine and feed
Székely et al. Efficacy of fumagillin against Myxidium giardi Cepede, 1906 infection of the European eel (Anguilla anguilla): new observations on myxidiosis of imported glass eels
Bowser et al. Laboratory efficacy of enrofloxacin for the control of Aeromonas salmonicida infection in rainbow trout
CN1290429C (en) Infectious disease preventive/remedy for fishes and shellfishes
Anirudhan et al. Alternative disease control methods in shrimp aquaculture: a review
JP2923263B2 (en) Feed composition for fish culture
JP2824185B2 (en) Fish immunostimulants
ABOUELEZZ et al. Effect of Nigella sativa on growth performance and some blood constituents of Nile Tilapia (Oreochromis Niloticus)
JP2001008636A (en) Feed composition for preventing infectious disease
JPH06234651A (en) Preventive medicine for infectious disease of fish
坂井勝信 et al. Attempt to control BKD by dietary modification and erythromycin chemotherapy in hatchery-reared masu salmon Oncorhynchus masou BREVOORT.
Zaeroni et al. EFFECT OF BETEL LEAF EXTRACT (Piper betle L.) ON Aeromonas hydrophila DISEASES IN TILAPIA (Oreochromis niloticus) SEED
TW526060B (en) Animal feedstuff and its additive
Azhar et al. Application of kappa-carrageenan as immunostimulant agent in non-specific defense system of vannamei shrimp
WO2004084922A1 (en) Infection inhibitor for fishes and shellfishes

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20070808

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080808

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080808

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090808

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090808

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110808

Year of fee payment: 15

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110808

Year of fee payment: 15

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120808

Year of fee payment: 16

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130808

Year of fee payment: 17

EXPY Cancellation because of completion of term